RiverTown Therapeutics Inc.
A topic that is rarely covered among hair loss publications is the phenomenon of chemotherapy-induced alopecia and specifically, permanent chemotherapy-induced alopecia. Chemotherapy and Hair Loss Around 2 million people may develop breast cancer each year globally, according to the World Cancer Research Fund. For these people who receive a breast cancer diagnosis, one the most…
Read More
Once again, Follicle Thought is pleased to share some remarkable results from RiverTown Therapeutics’ RT1640. Precision Results The photos below include an alternate angle of a 6 month result which was previously shared in the RiverTown Game Changer article. This time an arrow has been added to the photo to indicate a birthmark for proper…
Read More
As we continue to await a meaningful treatment becoming available and/or progressing in the clinical trial setting, I have more photo results from RiverTown Therapeutics Inc. to share. This result is a continuation of a previous before and after of a 60 yr old male that has been shared on Follicle Thought from RiverTown. This…
Read More
RiverTown Therapeutics has engaged in an academic research collaboration to validate an effect of RT1640 that has already been observed in humans – gray hair reversal. A collaboration has begun between RiverTown Therapeutics and The University of Alabama at Birmingham with well-known hair pigment researcher Dr. Melissa Harris. You may remember Dr. Melissa Harris as…
Read More
The Guardian has reported the intriguing drug WAY-316606, which was originally developed for osteoporosis, may soon be entering human hair growth clinical trials with the help of an Italian pharmaceutical company. I was pleasantly surprised to find some worthwhile information in the latest “mainstream media baldness cure” article published by The Guardian today. I should…
Read MoreNew Beauty, a magazine covering the female aesthetics industry, has released a print article featuring “hair loss solutions.” The article contains quotes and information from Dr. George Cotsarelis, RiverTown Therapeutics, and Histogen. The Brotzu Lotion is also mentioned, though with information already known. Setipiprant For Females In the article, Dr. Cotsarelis shares that his lab…
Read More
Earlier this month, research coming out of the NIH and the University of Alabama made headlines for uncovering a piece of the biological puzzle which is the process of hair graying. The team behind the study determined that the immune system is highly involved in the proces of achromotrichia (hair graying) and that the transcription…
Read More
A lot has changed in the hair growth industry since I began Follicle Thought three years ago. Many new names and glimmers of hope have shown up in the industry. Even celebrity hair restoration has become more widespread and talked about. These are all positive developments which support the ultimate goal we are heading towards.…
Read More
I’ve had many readers inquire lately about the current progress of RiverTown Therapeutics Inc.’s RT1640. RTI’s therapy for hair regeneration, RT1640, is a topical medication composed of minoxidil, cyclosporine A, and a novel molecule called RT175. The company debuted some impressive hair growth photos on this site last year. The question that’s been on a…
Read More
I’ve got a good feeling about 2017… For the past several years we have been pacified by the news of a research study or startup company working on a treatment that grows hair. Ultimately, we would prefer the treatment in our hands, but reading about it on a computer screen has been supportive as well.…
Read More